In this context, several lines of evidence suggest that heme oxygenase-1 (HO-1) and its biological products (CO and biliverdin) represent a possible target for cancer therapy and to overcome chemoresistance [3,4,5,6,7]. The gene discussed is HMOX1; the disease is cancer.